American Society of Hirudotherapy

Tension-Type Headache

Investigational use for chronic tension-type headache; no study for this headache type was identified, and the proposed mechanism (muscle tension, venous congestion) is untested.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 17, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for tension-type headache. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for tension headache is investigational.
What evidence exists?
Tier C (investigational). No clinical study of leech therapy designed for tension-type headache was identified in the literature searches. The only related data are one small uncontrolled Russian series of 10 women with high blood pressure, whose tension-type headache scores fell after treatment, and a few reports in other headache types. A previously cited case series could not be verified and was removed. There are no randomized controlled trials. Headache trials are highly susceptible to placebo response. First-line treatments — tricyclics (amitriptyline), behavioral therapy, postural and ergonomic correction, biofeedback, physiotherapy — remain standard of care.
Main risks
  • Bleeding from bite sites for 6 to 24 hours after leech detachment
  • Bruising and tenderness over the trapezius, occiput, and temples for 3 to 7 days
  • Itching and irritation at bite sites for days to weeks
  • Local skin infection or, rarely, Aeromonas infection from leech gut bacteria
  • Allergic reaction to leech saliva (uncommon)
  • Temporary worsening of headache or neck pain for 1 to 2 days
  • Small bite marks that usually fade over weeks to months (rarely a pale spot stays longer)
  • Delay of amitriptyline trial, CBT, biofeedback, and exercise - all with RCT support
  • Placebo response masking medication-overuse headache or secondary causes
Who should not consider this
  • Patients taking blood thinners (warfarin, apixaban, rivaroxaban, dabigatran, heparin)
  • Patients with hemophilia or other bleeding disorders
  • Patients with anemia
  • Patients with a weakened immune system
  • Patients with active medication-overuse headache (taper analgesics first)
  • Patients with secondary headache (rule out structural/infectious cause first)
  • Patients with red-flag headache features (sudden onset, neurological deficits, fever, immunosuppression, cancer history, age over 50 new-onset)
  • Patients who have not tried amitriptyline (or alternative) at adequate dose and duration
  • Patients with untreated depression or anxiety driving the headache
  • Patients with active dermatitis or broken skin at planned placement sites
What to ask your clinician
  • Have I had medication-overuse headache and secondary causes ruled out?
  • Have I completed an adequate trial of amitriptyline, physical therapy, biofeedback, and ergonomic correction?
  • What evidence supports leech therapy for tension headache specifically?
  • What is the practitioner's experience and Aeromonas-prevention plan?
  • What is the realistic chance of benefit, given the tiny published evidence base?
  • What is the cost, and what does it commit me to?
  • Have we excluded migraine, cluster headache, cervicogenic headache, and medication-overuse headache?
When to seek urgent care
  • New or progressive neurologic symptoms — weakness, numbness, speech difficulty, vision change
  • Sudden worst headache of life (call 911)
  • Headache with fever, neck stiffness, or confusion
  • Bleeding from bite sites lasting more than 24 to 48 hours
  • Spreading redness, warmth, pus, or red streaks at bite sites
  • Fever above 38.0 C / 100.4 F or chills
  • Hives, throat tightness, or breathing difficulty
  • Jaw claudication, scalp tenderness, or vision change in age over 50 (possible giant cell arteritis)
  • New-onset headache during pregnancy or postpartum

What this does NOT mean

  • This is not FDA-cleared for tension-type headache.
  • Uncontrolled case reports or series are not evidence of efficacy in the general population.
  • Mechanism rationale (muscle decongestion, anti-inflammatory peptides) does NOT establish clinical efficacy.
  • Leech therapy does not address underlying drivers (medication overuse, postural, psychological).
  • Reported benefit in a small series does not predict your individual response.
  • It does not replace evidence-based prevention with RCT support.

Clinical Profile

Category
Neurological
ICD-10
G44.209, G44.219, G44.229
Safety tier
Low

Evidence Summary

No controlled trial and no study of leech therapy designed for tension-type headache was identified in PubMed, Europe PMC, ClinicalTrials.gov or Russian- and German-language searches. The only clinical data found are indirect: a Russian before-and-after series of 10 women with grade 1-2 hypertension, all with tension-type headache by questionnaire, reported lower headache scores after leech therapy (Chufarovskaya 2011; uncontrolled, with antihypertensive doses being reduced at the same time). Reports in other headache types are limited to a 7-patient migraine case series (Ansari 2019) and a single cluster-headache case report (Bhat 2024). A proposed mechanism (reduction of pericranial muscle tension via local anti-inflammatory salivary peptides plus venous decongestion) is untested. The evidence base is insufficient to recommend leech therapy over conventional management (tricyclics, biofeedback, physiotherapy); medication-overuse headache should be excluded before any adjunctive use is considered, and use remains investigational.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Medication-overuse headache (taper analgesics first)
  • Cervical instability or vertebrobasilar insufficiency

Related Conditions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.